ArticleNorthern clinics of Istanbul2025
Identifying prognostic clues in CMV anterior uveitis: The role of corneal endothelitis and seasonal relapse patterns.
Article in Northern clinics of Istanbul, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo characterise the clinical spectrum, prognostic indicators and seasonal relapse patterns of cytomegalovirus anterior uveitis (CMV-AU), with particular emphasis on glaucoma risk and treatment outcomes.
methodsThis retrospective study analysed 53 eyes of 52 immunocompetent patients diagnosed with CMV-AU between 2019 and 2023 at a tertiary referral centre. Diagnosis relied on characteristic clinical findings and, in selected cases, aqueous-humour polymerase chain reaction (PCR) testing. Demographic data, best-corrected visual acuity (BCVA), intraocular pressure (IOP), keratic precipitate (KP) patterns, anterior segment changes, treatment regimens and relapse rates were reviewed.
resultsThe cohort (67.3% male) had a mean diagnosis age of 34.3±11.1 years. Most eyes were Posner-Schlossmann-like (63.5%), followed by chronic non-specific AU (34.6 %) and Fuchs-like AU (1.9 %). KPs were chiefly solitary (58.5%), centrally located (50.9%) and sparse (< 5) in 66.0 %. Corneal endothelitis occurred in 39.6% of eyes and was an independent predictor of secondary glaucoma (OR=6.20, 95 % CI 1.04-36.86). Glaucoma developed in 56.6% of eyes; 13.2% required glaucoma surgery. Glaucoma was more frequent and more likely to require surgery in patients treated with oral valganciclovir compared to those treated with topical ganciclovir alone (p=0.049 and p=0.034, respectively). Having ≥ 1 winter relapse (OR=4.99, 95 % CI 1.14-21.86) and, in women, ≥1 spring relapse (OR=5.38, 95 % CI 1.11-25.96) independently predicted > 3 relapses. Overall relapse frequency peaked in winter and summer (p<0.05).
conclusionCorneal endothelitis appears to be an independent risk factor for secondary glaucoma in CMV-AU, warranting vigilant IOP monitoring and timely antiviral therapy. The observed seasonal pattern, with more frequent relapses in winter overall and an increased rate in spring among female patients, may assist clinicians in identifying high-risk groups and planning closer follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.